Indigo Diabetes N.V. (Indigo) is a pioneering developer of medical devices for people living with chronic diseases. Using its proprietary nanophotonics technology the Company is developing the world’s first subcutaneously implanted Continuous Multi-Metabolite Monitoring (CMM®) sensor to provide people living with chronic diseases access to information on their metabolite levels at any time, without the need to wear an external device on their body. Indigo is initially focused on diabetes to address the need for continuous and accurate glucose, ketone, and lactate monitoring. Indigo is headquartered in Ghent, Belgium, and also has employees based in the US.
| Website | http://www.indigomed.com |
| Revenue | $4 million |
| Employees | 33 (29 on RocketReach) |
| Founded | 2016 |
| Address | 2b Bollebergen Bus 30, Gent 9052, BE |
| Phone | +32 475 41 21 32 |
| Technologies |
JavaScript
,
HTML
,
PHP
+23 more
(view full list)
|
| Industry | Retail, Medical Equipment Manufacturing, Diabetes, Health Care, Medical, Medical Device |
| Keywords | Medical Devices, Chronic Disease Treatment, Diabetes Management, Sensor Technology, Continuous Glucose Monitoring, Implantable Sensors, Biomedical Engineering, Therapeutic Devices, Minimally Invasive Devices, Biosensors, Healthcare Technology, Nanotechnology, Precision Medicine, Drug Delivery, Medical Technology, Digital Health, Medical Innovation, Health Tech |
| Competitors | Adyen, Worldpay, PayPal, Stripe, Klarna, Square, Braintree, 2Checkout (now Verifone), Bluefin Payment Systems, Authorize.net +36 more (view full list) |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 334 Companies, NAICS Code 33 Companies |
Looking for a particular Indigo employee's phone or email?
The Indigo annual revenue was $4 million in 2026.
Emmet Lydon is the Chief Operating Officer at Indigo Diabetes of Indigo.
29 people are employed at Indigo.
The NAICS codes for Indigo are [334, 33].
The SIC codes for Indigo are [38, 384].